The miRNA Sequencing and Assay market is anticipated to grow with a CAGR of 10.9%, during the forecast period. The significant factor attributing to the growth is the rising prevalence of infectious diseases, the development of novel technology and the introduction of different techniques to assess the miRNA sequence will boost the market growth for miRNA sequencing and assay market during the forecast market. In the diagnostics and prognostics industry, the miRNA sequencing method has the ability to become an essential tool. Increasing popularity for cost-effective sequencing methods, rising cancer incidence, and increasing activities in genomics research will also propel the market demand for miRNA sequencing and assay in the coming years.
Scope of the Report
miRNA sequencing is a type of RNA-seq, which uses the next-generation sequencing or massively parallel sequencing of high-throughput DNA to pattern microRNAs. The substance used during the method of decoding miRNA; this sequencing is a bit different from RNA sequencing.
Key Market Trends
Library preparation kits are Expected to Hold the Largest Market Share in the miRNA Sequencing and Assay Market
- Dominant share is retained by the library preparation kits segment owing to the attributes such as rising genome-related research and growing cancer research and owing to the high demand for next-generation sequencing technology for all the research because it has the ability to deliver the potential healthcare solution.
- The growth of the segment can be also attributed to the high prevalence of chronic diseases such as cancer and infectious diseases. Rising chronic diseases are a global challenge, account for around 60% of all fatalities globally, as per the WHO estimates.
- As per the statistics from GLOBOCAN 2018, worldwide 2,088,849 individuals have breast cancer. Asia remains the leading contributor in the rising incidence of breast cancer with a reported share of 43.6% followed by Europe, North and Latin America, Africa, and Oceania with a share of 25%, 12.6% and 9.6%, 8.1%, and 1.2% respectively.
North America Dominates the Market and Expected to do Same in the Forecast Period
Owing to the increasing adoption of advanced technologies, this region is gaining a high market share. This is owing to factors such as rising initiatives to carry out research and development activities are the key factor in this market's growth in the region. Growing numbers of infectious diseases are the key driver of market growth. However, the demand is driven by rising incidence cases of cancer. Factors such as the availability of world-class academics and research facilities committed to genome research increased government funding for genetic research, and increased demand for technological, high-throughput technologies for miRNA research are additional factors boosting the region share at the global level during the forecast period.
The miRNA sequencing and assay market is moderately competitive and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions with the other companies and launching new products to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Illumina, Inc., Thermo Fisher Scientific, Qiagen N.V., Perkinelmer, Inc., and Takara Bio, Inc.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client's requirements
- 3 months of analyst support
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 MiRNA Sequencing and Assay Sequencing supremacy over other methods
4.2.2 Increased research in the field of genomics drive the miRNA sequencing adoption
4.2.3 Reduced sequencing costs
4.3 Market Restraints
4.3.1 Paucity of professional experts
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Sequencing Consumables
5.1.2 Library Preparation Kits
5.2 By Technology
5.2.1 Sequencing by Synthesis
5.2.2 Ion Semiconductor
5.2.4 Nanopore Sequencing
5.3 By End User
5.3.1 Clinical Laboratory
5.3.2 Life Science Organization
5.4.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
5.4.3 Asia Pacific
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.4.4 Middle East and Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle East and Africa
5.4.5 South America
184.108.40.206 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Illumina, Inc.
6.1.2 Thermo Fisher Scientific
6.1.3 Qiagen N.V.
6.1.4 PerkinElmer, Inc.
6.1.5 Takara Bio, Inc.
6.1.6 New England Biolabs, Inc.
6.1.7 Norgen Biotek Corporation
6.1.8 Trilink Biotechnologies
6.1.10 Oxford Nanopore Technologies
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.